Effect of octreotide on urine output during orthotopic Liver transplantatio
Phase 4
- Conditions
- iver Cirhosis.Fibrosis and cirhosis of liver
- Registration Number
- IRCT2012120411662N1
- Lead Sponsor
- Vice-Chancellery of Research and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 2012
Inclusion Criteria
All patients with end-stage liver disease who undergoing orthotropic deceased donor liver transplantation from sept 2011 to april 2012 .
Patients with history of diabetes mellitus; hypertension; ischemic heart disease ; heart block willbe excluded from study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rine Out Put. Timepoint: At the end of hepatectomy phase; Atthe end of an-hepatic phase; At the end of neohepatic phase. Method of measurement: With observation of urine volume per Kg (body weight) per hour.
- Secondary Outcome Measures
Name Time Method Postoperative Creatinine Level. Timepoint: On the 3rd day postoperation. Method of measurement: Jaffe/kinetic.